# Ciprofloxacin

NDC: 76420-928
Generic name: Ciprofolxacin
Labeler / Manufacturer: Asclemed USA, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET
Routes: ORAL
Marketing started: 20231001

FDA application: ANDA208921

## Active ingredients

- CIPROFLOXACIN HYDROCHLORIDE: 250 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"76420-928"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=76420-928
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c4eecdf8-9e50-4e44-aca1-b9c19317d52a